{"transactions":[{"id":1274,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":1063,"kind":"person","name":"Lieber Jonathan I","position":1,"cik":"0001350090","reported_name":"Lieber Jonathan I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-02T22:32:13.000Z","date":"2026-08-31","kind":"grant","planned":false,"acquired":true,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Restricted stock granted under the Decoy Therapeutics Inc. 2026 Equity Incentive Plan,  100 percent will vest on August 30, 2027."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares beneficially owned following the transaction have been adjusted to reflect the reverse stock splits effective on August 15, 2025 and March 6, 2026."}],"balance_after":2002,"source":{"system":"sec-edgar","filing":"0001193125-26-380584","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615219/000119312526380584/ownership.xml","form_type":"4"}},{"id":1156,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":976,"kind":"person","name":"PIERCE FREDERICK II","position":1,"cik":"0001229055","reported_name":"PIERCE FREDERICK II","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-09-02T21:50:33.000Z","date":"2026-08-31","kind":"grant","planned":false,"acquired":true,"shares":33455,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Restricted stock granted under the Decoy Therapeutics Inc. 2026 Equity Incentive Plan. 25 percent of the restricted stock vested immediately, and the remainder will vest in approximately equal monthly increments over the next 36 months."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares beneficially owned following the transaction have been adjusted to reflect the reverse stock split effective on March 6, 2026."}],"balance_after":34844,"source":{"system":"sec-edgar","filing":"0001229055-26-000002","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615219/000122905526000002/ownership.xml","form_type":"4"}},{"id":1149,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":971,"kind":"person","name":"Marschel Peter Klaus","position":1,"cik":"0002079859","reported_name":"Marschel Peter Klaus","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2026-09-02T21:49:41.000Z","date":"2026-08-31","kind":"grant","planned":false,"acquired":true,"shares":3900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Restricted stock granted under the Decoy Therapeutics Inc. 2026 Equity Incentive Plan. 25 percent of the restricted stock vested immediately, and the remainder will vest in approximately equal monthly increments over the next 36 months."}],"balance_after":3900,"source":{"system":"sec-edgar","filing":"0002079859-26-000002","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2079859/000207985926000002/ownership.xml","form_type":"4"}},{"id":1147,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":969,"kind":"person","name":"Rosenblum Mark J","position":1,"cik":"0001329154","reported_name":"Rosenblum Mark J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-09-02T21:48:11.000Z","date":"2026-08-31","kind":"grant","planned":false,"acquired":true,"shares":9682,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Restricted stock granted under the Decoy Therapeutics Inc. 2026 Equity Incentive Plan. 25 percent of the restricted stock vested immediately, and the remainder will vest in approximately equal monthly increments over the next 36 months."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares beneficially owned following the transaction have been adjusted to reflect the reverse stock splits effective on August 15, 2025 and March 6, 2026."}],"balance_after":11363,"source":{"system":"sec-edgar","filing":"0001329154-26-000003","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615219/000132915426000003/ownership.xml","form_type":"4"}},{"id":1127,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":963,"kind":"person","name":"Hibner Barbara Louise","position":1,"cik":"0002079512","reported_name":"Hibner Barbara Louise","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-09-02T21:46:59.000Z","date":"2026-08-31","kind":"grant","planned":false,"acquired":true,"shares":4216,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Restricted stock granted under the Decoy Therapeutics Inc. 2026 Equity Incentive Plan. 25 percent of the restricted stock vested immediately, and the remainder will vest in approximately equal monthly increments over the next 36 months."}],"balance_after":4216,"source":{"system":"sec-edgar","filing":"0002079512-26-000002","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2079512/000207951226000002/ownership.xml","form_type":"4"}},{"id":1123,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":959,"kind":"person","name":"HANISH ARNOLD C","position":1,"cik":"0001233253","reported_name":"HANISH ARNOLD C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-02T21:45:02.000Z","date":"2026-08-31","kind":"grant","planned":false,"acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Restricted stock granted under the Decoy Therapeutics Inc. 2026 Equity Incentive Plan,  100 percent will vest on August 30, 2027."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares beneficially owned following the transaction have been adjusted to reflect the reverse stock split effective on March 6, 2026."}],"balance_after":3418,"source":{"system":"sec-edgar","filing":"0001233253-26-000006","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615219/000123325326000006/ownership.xml","form_type":"4"}},{"id":1112,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":952,"kind":"person","name":"Lammers Paul","position":1,"cik":"0001457289","reported_name":"Lammers Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-02T21:42:21.000Z","date":"2026-08-31","kind":"grant","planned":false,"acquired":true,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Restricted stock granted under the Decoy Therapeutics Inc. 2026 Equity Incentive Plan,  100 percent will vest on August 30, 2027."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares beneficially owned following the transaction have been adjusted to reflect the reverse stock splits effective on August 15, 2025 and March 6, 2026."}],"balance_after":2001,"source":{"system":"sec-edgar","filing":"0001457289-26-000003","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615219/000145728926000003/ownership.xml","form_type":"4"}},{"id":1099,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":942,"kind":"person","name":"Burleson Tess","position":1,"cik":"0001769749","reported_name":"Burleson Tess","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-02T21:41:11.000Z","date":"2026-08-31","kind":"grant","planned":false,"acquired":true,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Restricted stock granted under the Decoy Therapeutics Inc. 2026 Equity Incentive Plan,  100 percent will vest on August 30, 2027."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares beneficially owned following the transaction have been adjusted to reflect the reverse stock splits effective on August 15, 2025 and March 6, 2026."}],"balance_after":2002,"source":{"system":"sec-edgar","filing":"0001769749-26-000003","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1769749/000176974926000003/ownership.xml","form_type":"4"}},{"id":1096,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":940,"kind":"person","name":"McVicar William K.","position":1,"cik":"0001634368","reported_name":"McVicar William K.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-02T21:40:16.000Z","date":"2026-08-31","kind":"grant","planned":false,"acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Restricted stock granted under the Decoy Therapeutics Inc. 2026 Equity Incentive Plan,  100 percent will vest on August 30, 2027."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares beneficially owned following the transaction have been adjusted to reflect the reverse stock splits effective on August 15, 2025 and March 6, 2026."}],"balance_after":3002,"source":{"system":"sec-edgar","filing":"0001634368-26-000003","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1634368/000163436826000003/ownership.xml","form_type":"4"}},{"id":1094,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":938,"kind":"person","name":"Gauthier Patricia G.","position":1,"cik":"0002148287","reported_name":"Gauthier Patricia G.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-02T21:39:18.000Z","date":"2026-08-31","kind":"grant","planned":false,"acquired":true,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Restricted stock granted under the Decoy Therapeutics Inc. 2026 Equity Incentive Plan, 100 percent will vest on August 30, 2027."}],"balance_after":2000,"source":{"system":"sec-edgar","filing":"0002148287-26-000002","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2148287/000214828726000002/ownership.xml","form_type":"4"}},{"id":955028,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":959,"kind":"person","name":"HANISH ARNOLD C","position":1,"cik":"0001233253","reported_name":"HANISH ARNOLD C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-02T22:13:54.000Z","date":"2025-12-30","kind":"sale","planned":false,"acquired":false,"shares":12,"price":0.6397,"value":7.6764,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001615219-26-000004","document":"wk-form4_1767392031.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1233253/000161521926000004/wk-form4_1767392031.xml","form_type":"4"}},{"id":955027,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":959,"kind":"person","name":"HANISH ARNOLD C","position":1,"cik":"0001233253","reported_name":"HANISH ARNOLD C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-02T22:13:54.000Z","date":"2025-12-30","kind":"sale","planned":false,"acquired":false,"shares":15,"price":0.6397,"value":9.5955,"ownership":{"direct":false,"nature":"By Arnold C. Hanish Trust"},"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001615219-26-000004","document":"wk-form4_1767392031.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1233253/000161521926000004/wk-form4_1767392031.xml","form_type":"4"}},{"id":989794,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":959,"kind":"person","name":"HANISH ARNOLD C","position":1,"cik":"0001233253","reported_name":"HANISH ARNOLD C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-24T22:08:13.000Z","date":"2025-11-20","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":0.7481,"value":3740.5,"ownership":{"direct":false,"nature":"By Arnold C. Hanish Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.7437 to $0.75, inclusive. The reporting person undertakes to provide to Salarius Pharmaceuticals, Inc., any security holder of Salarius Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4."}],"balance_after":5015,"source":{"system":"sec-edgar","filing":"0001615219-25-000193","document":"wk-form4_1764022090.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1233253/000161521925000193/wk-form4_1764022090.xml","form_type":"4"}},{"id":992351,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":969,"kind":"person","name":"Rosenblum Mark J","position":1,"cik":"0001329154","reported_name":"Rosenblum Mark J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec VP Finance, CFO"}}],"security":"Common Stock","published_at":"2025-11-20T16:42:09.000Z","date":"2025-11-20","kind":"purchase","planned":false,"acquired":true,"shares":20000,"price":0.8,"value":16000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares beneficially owned following the transaction is adjusted to reflect the reverse stock splits effective on June 16, 2024 and August 17, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 20 shares of unvested restricted stock granted on January 3, 2023."}],"balance_after":20177,"source":{"system":"sec-edgar","filing":"0001615219-25-000177","document":"wk-form4_1763674926.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1329154/000161521925000177/wk-form4_1763674926.xml","form_type":"4"}},{"id":1542382,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":92024,"kind":"person","name":"Arthur David J.","position":1,"cik":"0001769331","reported_name":"Arthur David J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-04-12T20:50:27.000Z","date":"2024-04-11","kind":"grant","planned":false,"acquired":true,"shares":20500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":20500,"derivative":{"exercise_price":0.51,"exercise_date":"2025-04-11","expiration_date":"2034-04-11","underlying":"Common Stock","underlying_shares":20500},"source":{"system":"sec-edgar","filing":"0001615219-24-000034","document":"wk-form4_1712955014.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615219/000161521924000034/wk-form4_1712955014.xml","form_type":"4"}},{"id":1624598,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":940,"kind":"person","name":"McVicar William K.","position":1,"cik":"0001634368","reported_name":"McVicar William K.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-02-22T21:29:33.000Z","date":"2024-02-20","kind":"grant","planned":false,"acquired":true,"shares":20500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":20500,"derivative":{"exercise_price":0.5711,"exercise_date":"2025-02-20","expiration_date":"2034-02-19","underlying":"Common Stock","underlying_shares":20500},"source":{"system":"sec-edgar","filing":"0001615219-24-000013","document":"wk-form4_1708637336.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615219/000161521924000013/wk-form4_1708637336.xml","form_type":"4"}},{"id":1624597,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":93978,"kind":"person","name":"McCreedy Bruce J Jr.","position":1,"cik":"0001769750","reported_name":"McCreedy Bruce J Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-02-22T21:25:02.000Z","date":"2024-02-20","kind":"grant","planned":false,"acquired":true,"shares":20500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":20500,"derivative":{"exercise_price":0.5711,"exercise_date":"2025-02-20","expiration_date":"2034-02-19","underlying":"Common Stock","underlying_shares":20500},"source":{"system":"sec-edgar","filing":"0001615219-24-000011","document":"wk-form4_1708637069.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615219/000161521924000011/wk-form4_1708637069.xml","form_type":"4"}},{"id":1624596,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":942,"kind":"person","name":"Burleson Tess","position":1,"cik":"0001769749","reported_name":"Burleson Tess","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-02-22T21:13:07.000Z","date":"2024-02-20","kind":"grant","planned":false,"acquired":true,"shares":20500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":20500,"derivative":{"exercise_price":0.5711,"exercise_date":"2025-02-20","expiration_date":"2034-02-19","underlying":"Common Stock","underlying_shares":20500},"source":{"system":"sec-edgar","filing":"0001615219-24-000005","document":"wk-form4_1708636372.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615219/000161521924000005/wk-form4_1708636372.xml","form_type":"4"}},{"id":1625025,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":959,"kind":"person","name":"HANISH ARNOLD C","position":1,"cik":"0001233253","reported_name":"HANISH ARNOLD C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-02-22T21:09:35.000Z","date":"2024-02-20","kind":"grant","planned":false,"acquired":true,"shares":20500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":20500,"derivative":{"exercise_price":0.5711,"exercise_date":"2025-02-20","expiration_date":"2034-02-19","underlying":"Common Stock","underlying_shares":20500},"source":{"system":"sec-edgar","filing":"0001615219-24-000003","document":"wk-form4_1708636159.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1233253/000161521924000003/wk-form4_1708636159.xml","form_type":"4"}},{"id":1624979,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":969,"kind":"person","name":"Rosenblum Mark J","position":1,"cik":"0001329154","reported_name":"Rosenblum Mark J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec VP Finance, CFO"}}],"security":"Stock Option (right to buy)","published_at":"2024-02-22T16:37:10.000Z","date":"2024-02-20","kind":"grant","planned":false,"acquired":true,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the options are vested on  February 20, 2025, and 1/36 of the remaining options vest on each monthly anniversary thereafter for 36 months."}],"balance_after":22500,"derivative":{"exercise_price":0.5711,"exercise_date":"2025-02-20","expiration_date":"2034-02-19","underlying":"Common Stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0001615219-24-000015","document":"wk-form4_1708637819.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1329154/000161521924000015/wk-form4_1708637819.xml","form_type":"4"}},{"id":1625104,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":1063,"kind":"person","name":"Lieber Jonathan I","position":1,"cik":"0001350090","reported_name":"Lieber Jonathan I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-02-22T16:21:15.000Z","date":"2024-02-20","kind":"grant","planned":false,"acquired":true,"shares":20500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":20500,"derivative":{"exercise_price":0.5711,"exercise_date":"2025-02-20","expiration_date":"2034-02-19","underlying":"Common Stock","underlying_shares":20500},"source":{"system":"sec-edgar","filing":"0001615219-24-000009","document":"wk-form4_1708636836.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1350090/000161521924000009/wk-form4_1708636836.xml","form_type":"4"}},{"id":1625227,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":952,"kind":"person","name":"Lammers Paul","position":1,"cik":"0001457289","reported_name":"Lammers Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-02-22T16:16:01.000Z","date":"2024-02-20","kind":"grant","planned":false,"acquired":true,"shares":20500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":20500,"derivative":{"exercise_price":0.5711,"exercise_date":"2025-02-20","expiration_date":"2034-02-19","underlying":"Common Stock","underlying_shares":20500},"source":{"system":"sec-edgar","filing":"0001615219-24-000007","document":"wk-form4_1708636513.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1457289/000161521924000007/wk-form4_1708636513.xml","form_type":"4"}},{"id":2013176,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":92024,"kind":"person","name":"Arthur David J.","position":1,"cik":"0001769331","reported_name":"Arthur David J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-02-15T21:04:16.000Z","date":"2023-02-13","kind":"grant","acquired":true,"shares":14300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock granted under the Salarius Pharmaceuticals, Inc. 2015 Equity Incentive Plan in lieu of cash for performance bonus. The shares of common stock are subject to a six-month holding period pursuant to the terms of the restricted stock agreement."}],"balance_after":48019,"source":{"system":"sec-edgar","filing":"0001615219-23-000023","document":"wf-form4_167649503732734.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615219/000161521923000023/wf-form4_167649503732734.xml","form_type":"4"}},{"id":2013284,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":969,"kind":"person","name":"Rosenblum Mark J","position":1,"cik":"0001329154","reported_name":"Rosenblum Mark J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec VP Finance, CFO"}}],"security":"Common Stock","published_at":"2023-02-15T16:06:23.000Z","date":"2023-02-13","kind":"grant","acquired":true,"shares":6432,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock granted under the Salarius Pharmaceuticals, Inc. 2015 Equity Incentive Plan in lieu of cash for performance bonus. The shares of common stock are subject to a six-month holding period pursuant to the terms of the restricted stock agreement"}],"balance_after":21851,"source":{"system":"sec-edgar","filing":"0001615219-23-000025","document":"wf-form4_167649515529108.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1329154/000161521923000025/wf-form4_167649515529108.xml","form_type":"4"}},{"id":2061694,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":93978,"kind":"person","name":"McCreedy Bruce J Jr.","position":1,"cik":"0001769750","reported_name":"McCreedy Bruce J Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-05T23:08:30.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":1440,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Restricted stock granted under the Salarius Pharmaceuticals, Inc.2015 Equity Incentive Plan. 100% of the restricted stock will vest on January 2, 2024"}],"balance_after":1788,"source":{"system":"sec-edgar","filing":"0001615219-23-000013","document":"wf-form4_167296009433418.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615219/000161521923000013/wf-form4_167296009433418.xml","form_type":"4"}},{"id":2062108,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":959,"kind":"person","name":"HANISH ARNOLD C","position":1,"cik":"0001233253","reported_name":"HANISH ARNOLD C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-05T23:06:21.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":1440,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Restricted stock granted under the Salarius Pharmaceuticals, Inc.2015 Equity Incentive Plan. 100% of the restricted stock will vest on January 2, 2024"}],"balance_after":1440,"source":{"system":"sec-edgar","filing":"0001615219-23-000011","document":"wf-form4_167295996189260.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1233253/000161521923000011/wf-form4_167295996189260.xml","form_type":"4"}},{"id":2061696,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":942,"kind":"person","name":"Burleson Tess","position":1,"cik":"0001769749","reported_name":"Burleson Tess","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-05T22:47:03.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":1440,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Restricted stock granted under the Salarius Pharmaceuticals, Inc.2015 Equity Incentive Plan. 100% of the restricted stock will vest on January 2, 2024"}],"balance_after":2722,"source":{"system":"sec-edgar","filing":"0001615219-23-000008","document":"wf-form4_167295879982131.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615219/000161521923000008/wf-form4_167295879982131.xml","form_type":"4"}},{"id":2061692,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":940,"kind":"person","name":"McVicar William K.","position":1,"cik":"0001634368","reported_name":"McVicar William K.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-05T22:44:25.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":1440,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Restricted stock granted under the Salarius Pharmaceuticals, Inc.2015 Equity Incentive Plan. 100% of the restricted stock will vest on January 2, 2024"}],"balance_after":1788,"source":{"system":"sec-edgar","filing":"0001615219-23-000006","document":"wf-form4_167295864858566.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615219/000161521923000006/wf-form4_167295864858566.xml","form_type":"4"}},{"id":2061688,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":92024,"kind":"person","name":"Arthur David J.","position":1,"cik":"0001769331","reported_name":"Arthur David J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-01-05T22:33:03.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Restricted stock granted under the Salarius Pharmaceuticals, Inc.2015 Equity Incentive Plan. 25% of the shares of restricted stock will vest on January 2, 2024, and 1/36 of the remaining shares of restricted stock will vest on monthly anniversary thereafter."}],"balance_after":33719,"source":{"system":"sec-edgar","filing":"0001615219-23-000002","document":"wf-form4_167295795521891.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615219/000161521923000002/wf-form4_167295795521891.xml","form_type":"4"}},{"id":2062243,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":1063,"kind":"person","name":"Lieber Jonathan I","position":1,"cik":"0001350090","reported_name":"Lieber Jonathan I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-05T18:12:03.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":1440,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Restricted stock granted under the Salarius Pharmaceuticals, Inc.2015 Equity Incentive Plan. 100% of the restricted stock will vest on January 2, 2024"}],"balance_after":2940,"source":{"system":"sec-edgar","filing":"0001615219-23-000015","document":"wf-form4_167296030411994.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1350090/000161521923000015/wf-form4_167296030411994.xml","form_type":"4"}},{"id":2062491,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":952,"kind":"person","name":"Lammers Paul","position":1,"cik":"0001457289","reported_name":"Lammers Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-05T18:03:02.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":1440,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Restricted stock granted under the Salarius Pharmaceuticals, Inc.2015 Equity Incentive Plan. 100% of the restricted stock will vest on January 2, 2024"}],"balance_after":1718,"source":{"system":"sec-edgar","filing":"0001615219-23-000010","document":"wf-form4_167295975197703.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1457289/000161521923000010/wf-form4_167295975197703.xml","form_type":"4"}},{"id":2061955,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":969,"kind":"person","name":"Rosenblum Mark J","position":1,"cik":"0001329154","reported_name":"Rosenblum Mark J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec VP Finance, CFO"}}],"security":"Common Stock","published_at":"2023-01-05T17:35:53.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Restricted stock granted under the Salarius Pharmaceuticals, Inc.2015 Equity Incentive Plan. 25% of the shares of restricted stock will vest on January 2, 2024, and 1/36 of the remaining shares of restricted stock will vest on monthly anniversary thereafter."}],"balance_after":15419,"source":{"system":"sec-edgar","filing":"0001615219-23-000004","document":"wf-form4_167295812977872.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1329154/000161521923000004/wf-form4_167295812977872.xml","form_type":"4"}},{"id":2089284,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":92024,"kind":"person","name":"Arthur David J.","position":1,"cik":"0001769331","reported_name":"Arthur David J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-12-12T23:34:44.000Z","date":"2022-11-03","kind":"grant","acquired":true,"shares":2693,"price":1.734,"value":4669.662,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person's previous Form 4 filed on November 7, 2022 and amended on November 8, 2022 incorrectly reported the Reporting Person acquiring 10,000 shares of common stock under the Salarius Pharmaceuticals, Inc. 2015 Employee Stock Purchase Plan, as amended, in transactions that were exempt under both Rule 16b-3(d) and Rule Rule 16b-3(c), when it should have been reported as 2,693 shares of common stock."}],"balance_after":13719,"source":{"system":"sec-edgar","filing":"0001615219-22-000155","document":"wf-form4a_167088805437684.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615219/000161521922000155/wf-form4a_167088805437684.xml","form_type":"4/A","original_submission_date":"2022-11-07"}},{"id":2089421,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":969,"kind":"person","name":"Rosenblum Mark J","position":1,"cik":"0001329154","reported_name":"Rosenblum Mark J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec VP Finance, CFO"}}],"security":"Common Stock","published_at":"2022-12-12T18:29:33.000Z","date":"2022-11-03","kind":"grant","acquired":true,"shares":1488,"price":1.734,"value":2580.192,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person's previous Form 4 filed on November 7, 2022 and amended on November 8, 2022 incorrectly reported the Reporting Person acquiring 7,314 shares of common stock under the Salarius Pharmaceuticals, Inc. 2015 Employee Stock Purchase Plan, as amended, in transactions that were exempt under both Rule 16b-3(d) and Rule Rule 16b-3(c), when it should have been reported as 1,488 shares of common stock."}],"balance_after":7419,"source":{"system":"sec-edgar","filing":"0001615219-22-000153","document":"wf-form4a_167088775808803.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1329154/000161521922000153/wf-form4a_167088775808803.xml","form_type":"4/A","original_submission_date":"2022-11-07"}},{"id":2121998,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":92024,"kind":"person","name":"Arthur David J.","position":1,"cik":"0001769331","reported_name":"Arthur David J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-11-08T22:42:33.000Z","date":"2022-11-03","kind":"grant","acquired":true,"shares":10000,"price":1.734,"value":17340.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired under the Salarius Pharmaceuticals, Inc. 2015 Employee Stock Purchase Plan, as amended, in transactions that were exempt under both Rule 16b-3(d) and Rule Rule 16b-3(c)"}],"balance_after":21026,"source":{"system":"sec-edgar","filing":"0001615219-22-000144","document":"wf-form4a_166794733755240.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615219/000161521922000144/wf-form4a_166794733755240.xml","form_type":"4/A","original_submission_date":"2022-11-07"}},{"id":2122093,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":969,"kind":"person","name":"Rosenblum Mark J","position":1,"cik":"0001329154","reported_name":"Rosenblum Mark J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec VP Finance, CFO"}}],"security":"Common Stock","published_at":"2022-11-08T17:40:57.000Z","date":"2022-11-03","kind":"grant","acquired":true,"shares":7314,"price":1.734,"value":12682.476,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired under the Salarius Pharmaceuticals, Inc. 2015 Employee Stock Purchase Plan, as amended, in transactions that were exempt under both Rule 16b-3(d) and Rule Rule 16b-3(c)"}],"balance_after":13245,"source":{"system":"sec-edgar","filing":"0001615219-22-000143","document":"wf-form4a_166794723949586.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1329154/000161521922000143/wf-form4a_166794723949586.xml","form_type":"4/A","original_submission_date":"2022-11-07"}},{"id":2123180,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":92024,"kind":"person","name":"Arthur David J.","position":1,"cik":"0001769331","reported_name":"Arthur David J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-11-07T21:34:56.000Z","date":"2022-11-03","kind":"grant","acquired":true,"shares":10000,"price":1.734,"value":17340.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired under the Salarius Pharmaceuticals, Inc. 2015 Employee Stock Purchase Plan, as amended, in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":285674,"source":{"system":"sec-edgar","filing":"0001615219-22-000142","document":"wf-form4_166785687791752.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615219/000161521922000142/wf-form4_166785687791752.xml","form_type":"4"}},{"id":2123316,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":969,"kind":"person","name":"Rosenblum Mark J","position":1,"cik":"0001329154","reported_name":"Rosenblum Mark J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec VP Finance, CFO"}}],"security":"Common Stock","published_at":"2022-11-07T16:33:50.000Z","date":"2022-11-03","kind":"grant","acquired":true,"shares":7314,"price":1.734,"value":12682.476,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired under the Salarius Pharmaceuticals, Inc. 2015 Employee Stock Purchase Plan, as amended, in transactions that were exempt under both Rule 16b-3(d) and Rule Rule 16b-3(c)."}],"balance_after":155633,"source":{"system":"sec-edgar","filing":"0001615219-22-000141","document":"wf-form4_166785680873414.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1329154/000161521922000141/wf-form4_166785680873414.xml","form_type":"4"}},{"id":2238672,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":942,"kind":"person","name":"Burleson Tess","position":1,"cik":"0001769749","reported_name":"Burleson Tess","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-08T19:14:30.000Z","date":"2022-06-07","kind":"purchase","acquired":true,"shares":27700,"price":0.18,"value":4986.0,"ownership":{"direct":true},"balance_after":32050,"source":{"system":"sec-edgar","filing":"0001615219-22-000101","document":"wf-form4_165471565849028.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615219/000161521922000101/wf-form4_165471565849028.xml","form_type":"4"}},{"id":2238972,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":1063,"kind":"person","name":"Lieber Jonathan I","position":1,"cik":"0001350090","reported_name":"Lieber Jonathan I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-08T15:12:16.000Z","date":"2022-06-07","kind":"purchase","acquired":true,"shares":37500,"price":0.1871,"value":7016.25,"ownership":{"direct":true},"balance_after":37500,"source":{"system":"sec-edgar","filing":"0001615219-22-000099","document":"wf-form4_165471551887755.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1350090/000161521922000099/wf-form4_165471551887755.xml","form_type":"4"}},{"id":2239880,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":940,"kind":"person","name":"McVicar William K.","position":1,"cik":"0001634368","reported_name":"McVicar William K.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-07T20:33:19.000Z","date":"2022-06-06","kind":"purchase","acquired":true,"shares":26553,"price":0.1883,"value":4999.9299,"ownership":{"direct":false,"nature":"McVicar Family Trust"},"balance_after":26553,"source":{"system":"sec-edgar","filing":"0001615219-22-000097","document":"wf-form4_165463398025988.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615219/000161521922000097/wf-form4_165463398025988.xml","form_type":"4"}},{"id":2241606,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":959,"kind":"person","name":"HANISH ARNOLD C","position":1,"cik":"0001233253","reported_name":"HANISH ARNOLD C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-07T00:33:05.000Z","date":"2022-06-03","kind":"purchase","acquired":true,"shares":28000,"price":0.184,"value":5152.0,"ownership":{"direct":false,"nature":"By Arnold C. Hanish Trust"},"balance_after":46350,"source":{"system":"sec-edgar","filing":"0001615219-22-000095","document":"wf-form4_165456196752108.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1233253/000161521922000095/wf-form4_165456196752108.xml","form_type":"4"}},{"id":2241605,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":959,"kind":"person","name":"HANISH ARNOLD C","position":1,"cik":"0001233253","reported_name":"HANISH ARNOLD C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-07T00:31:19.000Z","date":"2020-08-21","kind":"purchase","acquired":true,"shares":4000,"price":0.98,"value":3920.0,"ownership":{"direct":false,"nature":"By Arnold C. Hanish Trust"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This Form 4/A is being filed to amend the Form 4 filed by the Reporting Person on August 24, 2020 to reflect that the securities reported are indirectly beneficially owned as indicated herein."}],"balance_after":11350,"source":{"system":"sec-edgar","filing":"0001615219-22-000093","document":"wf-form4a_165456185934953.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1233253/000161521922000093/wf-form4a_165456185934953.xml","form_type":"4/A","original_submission_date":"2020-08-24"}},{"id":2241604,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":959,"kind":"person","name":"HANISH ARNOLD C","position":1,"cik":"0001233253","reported_name":"HANISH ARNOLD C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-07T00:28:43.000Z","date":"2020-02-11","kind":"purchase","acquired":true,"shares":4350,"price":1.15,"value":5002.5,"ownership":{"direct":false,"nature":"By Arnold C. Hanish Trust"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This Form 4/A is being filed to amend the Form 4 filed by the Reporting Person on February 12, 2020 to reflect that the securities reported are indirectly beneficially owned as indicated herein."}],"balance_after":7350,"source":{"system":"sec-edgar","filing":"0001615219-22-000091","document":"wf-form4a_165456170682482.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1233253/000161521922000091/wf-form4a_165456170682482.xml","form_type":"4/A","original_submission_date":"2020-02-12"}},{"id":2241603,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":959,"kind":"person","name":"HANISH ARNOLD C","position":1,"cik":"0001233253","reported_name":"HANISH ARNOLD C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-07T00:27:03.000Z","date":"2019-11-25","kind":"purchase","acquired":true,"shares":3000,"price":3.59,"value":10770.0,"ownership":{"direct":false,"nature":"By Arnold C. Hanish Trust"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This Form 4/A is being filed to amend the Form 4 filed by the Reporting Person on November 26, 2019 to reflect that the securities reported are indirectly beneficially owned as indicated herein."}],"balance_after":3000,"source":{"system":"sec-edgar","filing":"0001615219-22-000089","document":"wf-form4a_165456160903374.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1233253/000161521922000089/wf-form4a_165456160903374.xml","form_type":"4/A","original_submission_date":"2019-11-26"}},{"id":2250870,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":92024,"kind":"person","name":"Arthur David J.","position":1,"cik":"0001769331","reported_name":"Arthur David J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-05-31T21:17:24.000Z","date":"2022-05-26","kind":"purchase","acquired":true,"shares":10800,"price":0.1843,"value":1990.44,"ownership":{"direct":false,"nature":"By daughter"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose."}],"balance_after":303574,"source":{"system":"sec-edgar","filing":"0001615219-22-000087","document":"wf-form4_165403182105530.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1615219/000161521922000087/wf-form4_165403182105530.xml","form_type":"4"}},{"id":2250869,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":92024,"kind":"person","name":"Arthur David J.","position":1,"cik":"0001769331","reported_name":"Arthur David J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-05-31T21:17:24.000Z","date":"2022-05-26","kind":"purchase","acquired":true,"shares":10392,"price":0.1799,"value":1869.5208,"ownership":{"direct":false,"nature":"By son"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose."}],"balance_after":292774,"source":{"system":"sec-edgar","filing":"0001615219-22-000087","document":"wf-form4_165403182105530.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1615219/000161521922000087/wf-form4_165403182105530.xml","form_type":"4"}},{"id":2250868,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":92024,"kind":"person","name":"Arthur David J.","position":1,"cik":"0001769331","reported_name":"Arthur David J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-05-31T21:17:24.000Z","date":"2022-05-26","kind":"purchase","acquired":true,"shares":708,"price":0.18,"value":127.44,"ownership":{"direct":false,"nature":"By son"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose."}],"balance_after":282382,"source":{"system":"sec-edgar","filing":"0001615219-22-000087","document":"wf-form4_165403182105530.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1615219/000161521922000087/wf-form4_165403182105530.xml","form_type":"4"}},{"id":2250867,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":92024,"kind":"person","name":"Arthur David J.","position":1,"cik":"0001769331","reported_name":"Arthur David J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-05-31T21:17:24.000Z","date":"2022-05-26","kind":"purchase","acquired":true,"shares":18600,"price":0.182,"value":3385.2,"ownership":{"direct":true},"balance_after":281674,"source":{"system":"sec-edgar","filing":"0001615219-22-000087","document":"wf-form4_165403182105530.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1615219/000161521922000087/wf-form4_165403182105530.xml","form_type":"4"}},{"id":2250866,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":92024,"kind":"person","name":"Arthur David J.","position":1,"cik":"0001769331","reported_name":"Arthur David J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-05-31T21:17:24.000Z","date":"2022-05-26","kind":"purchase","acquired":true,"shares":3400,"price":0.18,"value":612.0,"ownership":{"direct":true},"balance_after":263074,"source":{"system":"sec-edgar","filing":"0001615219-22-000087","document":"wf-form4_165403182105530.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615219/000161521922000087/wf-form4_165403182105530.xml","form_type":"4"}},{"id":2251011,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":969,"kind":"person","name":"Rosenblum Mark J","position":1,"cik":"0001329154","reported_name":"Rosenblum Mark J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec VP Finance, CFO"}}],"security":"Common Stock","published_at":"2022-05-31T17:13:28.000Z","date":"2022-05-31","kind":"purchase","acquired":true,"shares":28000,"price":0.18,"value":5040.0,"ownership":{"direct":true},"balance_after":148319,"source":{"system":"sec-edgar","filing":"0001615219-22-000085","document":"wf-form4_165403159108429.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1329154/000161521922000085/wf-form4_165403159108429.xml","form_type":"4"}},{"id":2280503,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":92024,"kind":"person","name":"Arthur David J.","position":1,"cik":"0001769331","reported_name":"Arthur David J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-05-05T20:06:21.000Z","date":"2022-05-03","kind":"grant","acquired":true,"shares":10000,"price":0.1863,"value":1863.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person voluntarily agreed to receive a percentage of his base salary in issuer shares  and receive these shares in lieu of net cash compensation. Shares are  purchased at a  price determined pursuant to the issuer's Employee Stock Purchase Plan."}],"balance_after":259674,"source":{"system":"sec-edgar","filing":"0001615219-22-000069","document":"wf-form4_165178116032585.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615219/000161521922000069/wf-form4_165178116032585.xml","form_type":"4"}},{"id":2280601,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":969,"kind":"person","name":"Rosenblum Mark J","position":1,"cik":"0001329154","reported_name":"Rosenblum Mark J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec VP Finance, CFO"}}],"security":"Common Stock","published_at":"2022-05-05T16:03:28.000Z","date":"2022-05-03","kind":"grant","acquired":true,"shares":10000,"price":0.1863,"value":1863.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person voluntarily agreed to receive a percentage of his base salary in issuer shares  and receive these shares in lieu of net cash compensation. Shares are  purchased at a  price determined pursuant to the issuer's Employee Stock Purchase Plan."}],"balance_after":120319,"source":{"system":"sec-edgar","filing":"0001615219-22-000067","document":"wf-form4_165178098962212.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1329154/000161521922000067/wf-form4_165178098962212.xml","form_type":"4"}},{"id":2341098,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":92024,"kind":"person","name":"Arthur David J.","position":1,"cik":"0001769331","reported_name":"Arthur David J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-03-09T21:01:55.000Z","date":"2022-03-03","kind":"purchase","acquired":true,"shares":139488,"price":0.391,"value":54539.808,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Registrant issued these shares to the reporting person as part of his bonus; which shares were issued in lieu of net cash compensation. The shares were issued at the fair market value of the Registrants common stock on the date of grant."}],"balance_after":249674,"source":{"system":"sec-edgar","filing":"0001615219-22-000018","document":"wf-form4_164685969931166.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615219/000161521922000018/wf-form4_164685969931166.xml","form_type":"4"}},{"id":2341358,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":969,"kind":"person","name":"Rosenblum Mark J","position":1,"cik":"0001329154","reported_name":"Rosenblum Mark J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec VP Finance, CFO"}}],"security":"Common Stock","published_at":"2022-03-09T16:03:00.000Z","date":"2022-03-03","kind":"purchase","acquired":true,"shares":76246,"price":0.391,"value":29812.186,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Registrant issued these shares to the reporting person as part of his bonus; which shares were issued in lieu of net cash compensation. The shares were issued at the fair market value of the Registrants common stock on the date of grant."}],"balance_after":110319,"source":{"system":"sec-edgar","filing":"0001615219-22-000019","document":"wf-form4_164685975971462.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1329154/000161521922000019/wf-form4_164685975971462.xml","form_type":"4"}},{"id":2428521,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":93978,"kind":"person","name":"McCreedy Bruce J Jr.","position":1,"cik":"0001769750","reported_name":"McCreedy Bruce J Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-01-21T21:11:51.000Z","date":"2022-01-20","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":30000,"derivative":{"exercise_price":0.48,"exercise_date":"2023-01-19","expiration_date":"2032-01-19","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001615219-22-000012","document":"wf-form4_164279949828430.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615219/000161521922000012/wf-form4_164279949828430.xml","form_type":"4"}},{"id":2428520,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":940,"kind":"person","name":"McVicar William K.","position":1,"cik":"0001634368","reported_name":"McVicar William K.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-01-21T21:09:04.000Z","date":"2022-01-20","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":30000,"derivative":{"exercise_price":0.48,"exercise_date":"2023-01-19","expiration_date":"2032-01-19","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001615219-22-000009","document":"wf-form4_164279932976878.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615219/000161521922000009/wf-form4_164279932976878.xml","form_type":"4"}},{"id":2428519,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":92024,"kind":"person","name":"Arthur David J.","position":1,"cik":"0001769331","reported_name":"Arthur David J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-01-21T21:08:11.000Z","date":"2022-01-20","kind":"grant","acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the options are fully vested on January 19, 2023, and 1/36 of the remaining options vest on each monthly anniversary thereafter."}],"balance_after":500000,"derivative":{"exercise_price":0.48,"expiration_date":"2032-01-19","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001615219-22-000008","document":"wf-form4_164279927781443.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615219/000161521922000008/wf-form4_164279927781443.xml","form_type":"4"}},{"id":2428518,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":942,"kind":"person","name":"Burleson Tess","position":1,"cik":"0001769749","reported_name":"Burleson Tess","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-01-21T21:07:01.000Z","date":"2022-01-20","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":30000,"derivative":{"exercise_price":0.48,"exercise_date":"2023-01-19","expiration_date":"2032-01-19","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001615219-22-000007","document":"wf-form4_164279920835445.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615219/000161521922000007/wf-form4_164279920835445.xml","form_type":"4"}},{"id":2428657,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":959,"kind":"person","name":"HANISH ARNOLD C","position":1,"cik":"0001233253","reported_name":"HANISH ARNOLD C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-01-21T21:06:07.000Z","date":"2022-01-20","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":30000,"derivative":{"exercise_price":0.48,"exercise_date":"2023-01-19","expiration_date":"2032-01-19","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001615219-22-000006","document":"wf-form4_164279914764399.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1233253/000161521922000006/wf-form4_164279914764399.xml","form_type":"4"}},{"id":2428662,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":1063,"kind":"person","name":"Lieber Jonathan I","position":1,"cik":"0001350090","reported_name":"Lieber Jonathan I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-01-21T16:10:03.000Z","date":"2022-01-20","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":30000,"derivative":{"exercise_price":0.48,"exercise_date":"2023-02-19","expiration_date":"2032-01-19","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001615219-22-000010","document":"wf-form4_164279938563168.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1350090/000161521922000010/wf-form4_164279938563168.xml","form_type":"4"}},{"id":2428698,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":952,"kind":"person","name":"Lammers Paul","position":1,"cik":"0001457289","reported_name":"Lammers Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-01-21T16:05:04.000Z","date":"2022-01-20","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":30000,"derivative":{"exercise_price":0.48,"exercise_date":"2023-01-19","expiration_date":"2032-01-19","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001615219-22-000005","document":"wf-form4_164279908733608.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1457289/000161521922000005/wf-form4_164279908733608.xml","form_type":"4"}},{"id":2428632,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":969,"kind":"person","name":"Rosenblum Mark J","position":1,"cik":"0001329154","reported_name":"Rosenblum Mark J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec VP Finance, CFO"}}],"security":"Stock Option (right to buy)","published_at":"2022-01-21T16:03:37.000Z","date":"2022-01-20","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the options are fully vested on January 19, 2023, and 1/36 of the remaining options vest on each monthly anniversary thereafter."}],"balance_after":200000,"derivative":{"exercise_price":0.48,"expiration_date":"2032-01-19","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001615219-22-000004","document":"wf-form4_164279899941926.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1329154/000161521922000004/wf-form4_164279899941926.xml","form_type":"4"}},{"id":2522471,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":92024,"kind":"person","name":"Arthur David J.","position":1,"cik":"0001769331","reported_name":"Arthur David J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-11-05T18:58:04.000Z","date":"2021-11-03","kind":"grant","acquired":true,"shares":7939,"price":0.718,"value":5700.202,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person voluntarily agreed to receive a percentage of his base salary in issuer shares and receive these shares in lieu of net cash compensation. Shares are purchased at a price determined pursuantto the issuer's Employee Stock Purchase Plan."}],"balance_after":110186,"source":{"system":"sec-edgar","filing":"0001615219-21-000096","document":"wf-form4_163613866819461.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615219/000161521921000096/wf-form4_163613866819461.xml","form_type":"4"}},{"id":2522669,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":969,"kind":"person","name":"Rosenblum Mark J","position":1,"cik":"0001329154","reported_name":"Rosenblum Mark J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec VP Finance, CFO"}}],"security":"Common Stock","published_at":"2021-11-05T14:54:02.000Z","date":"2021-11-03","kind":"grant","acquired":true,"shares":7787,"price":0.718,"value":5591.066,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person voluntarily agreed to receive a percentage of his base salary in issuer shares and receive these shares in lieu of net cash compensation. Shares are purchased at a price determined pursuant to the issuer's Employee Stock Purchase Plan."}],"balance_after":34073,"source":{"system":"sec-edgar","filing":"0001615219-21-000095","document":"wf-form4_163613842601112.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1329154/000161521921000095/wf-form4_163613842601112.xml","form_type":"4"}},{"id":2599270,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":92024,"kind":"person","name":"Arthur David J.","position":1,"cik":"0001769331","reported_name":"Arthur David J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-08-17T20:08:52.000Z","date":"2021-08-17","kind":"purchase","acquired":true,"shares":2000,"price":0.892,"value":1784.0,"ownership":{"direct":false,"nature":"By son"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose"}],"balance_after":102247,"source":{"system":"sec-edgar","filing":"0001615219-21-000087","document":"wf-form4_162923091089935.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1615219/000161521921000087/wf-form4_162923091089935.xml","form_type":"4"}},{"id":2599269,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":92024,"kind":"person","name":"Arthur David J.","position":1,"cik":"0001769331","reported_name":"Arthur David J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-08-17T20:08:52.000Z","date":"2021-08-17","kind":"purchase","acquired":true,"shares":2000,"price":0.899,"value":1798.0,"ownership":{"direct":false,"nature":"By daughter"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose"}],"balance_after":100247,"source":{"system":"sec-edgar","filing":"0001615219-21-000087","document":"wf-form4_162923091089935.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615219/000161521921000087/wf-form4_162923091089935.xml","form_type":"4"}},{"id":2606666,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":959,"kind":"person","name":"HANISH ARNOLD C","position":1,"cik":"0001233253","reported_name":"HANISH ARNOLD C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-11T20:08:04.000Z","date":"2021-08-10","kind":"purchase","acquired":true,"shares":7000,"price":0.881,"value":6167.0,"ownership":{"direct":false,"nature":"By Arnold C. Hanish Trust"},"balance_after":18350,"source":{"system":"sec-edgar","filing":"0001615219-21-000085","document":"wf-form4_162871242411942.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1233253/000161521921000085/wf-form4_162871242411942.xml","form_type":"4"}},{"id":2726400,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":92024,"kind":"person","name":"Arthur David J.","position":1,"cik":"0001769331","reported_name":"Arthur David J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-05-05T21:10:05.000Z","date":"2021-05-03","kind":"grant","acquired":true,"shares":9822,"price":0.567,"value":5569.074,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person voluntarily agreed to receive a percentage of his base salary in issuer shares and receive these shares in lieu of net cash compensation. Shares are purchased at a price determined pursuant to the issuer's Employee Stock Purchase Plan."}],"balance_after":96247,"source":{"system":"sec-edgar","filing":"0001615219-21-000040","document":"wf-form4_162024898808755.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615219/000161521921000040/wf-form4_162024898808755.xml","form_type":"4"}},{"id":2726775,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":969,"kind":"person","name":"Rosenblum Mark J","position":1,"cik":"0001329154","reported_name":"Rosenblum Mark J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec VP Finance, CFO"}}],"security":"Common Stock","published_at":"2021-05-05T17:11:53.000Z","date":"2021-05-03","kind":"grant","acquired":true,"shares":9563,"price":0.567,"value":5422.221,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person voluntarily agreed to receive a percentage of his base salary in issuer shares and receive these shares in lieu of net cash compensation. Shares are purchased at a price determined pursuant to the issuer's Employee Stock Purchase Plan."}],"balance_after":26286,"source":{"system":"sec-edgar","filing":"0001615219-21-000042","document":"wf-form4_162024909680344.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1329154/000161521921000042/wf-form4_162024909680344.xml","form_type":"4"}},{"id":2956221,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":942,"kind":"person","name":"Burleson Tess","position":1,"cik":"0001769749","reported_name":"Burleson Tess","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-12-04T22:07:45.000Z","date":"2020-12-02","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":30000,"derivative":{"exercise_price":0.74,"exercise_date":"2021-12-01","expiration_date":"2030-12-01","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001615219-20-000123","document":"wf-form4_160711965088199.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615219/000161521920000123/wf-form4_160711965088199.xml","form_type":"4"}},{"id":2956220,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":92024,"kind":"person","name":"Arthur David J.","position":1,"cik":"0001769331","reported_name":"Arthur David J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-12-04T22:05:05.000Z","date":"2020-12-02","kind":"grant","acquired":true,"shares":275000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the options are fully vested on December 1, 2021, and 1/36 of the remaining options vest on each monthly anniversary thereafter."}],"balance_after":275000,"derivative":{"exercise_price":0.74,"expiration_date":"2030-12-01","underlying":"Common Stock","underlying_shares":275000},"source":{"system":"sec-edgar","filing":"0001615219-20-000122","document":"wf-form4_160711949187470.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615219/000161521920000122/wf-form4_160711949187470.xml","form_type":"4"}},{"id":2956219,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":940,"kind":"person","name":"McVicar William K.","position":1,"cik":"0001634368","reported_name":"McVicar William K.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-12-04T22:03:59.000Z","date":"2020-12-02","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":30000,"derivative":{"exercise_price":0.74,"exercise_date":"2021-12-01","expiration_date":"2030-12-01","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001615219-20-000121","document":"wf-form4_160711942230730.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615219/000161521920000121/wf-form4_160711942230730.xml","form_type":"4"}},{"id":2956384,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":959,"kind":"person","name":"HANISH ARNOLD C","position":1,"cik":"0001233253","reported_name":"HANISH ARNOLD C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-12-04T22:00:32.000Z","date":"2020-12-02","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":30000,"derivative":{"exercise_price":0.74,"exercise_date":"2021-12-01","expiration_date":"2030-12-01","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001615219-20-000119","document":"wf-form4_160711921909433.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1233253/000161521920000119/wf-form4_160711921909433.xml","form_type":"4"}},{"id":2956218,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":93978,"kind":"person","name":"McCreedy Bruce J Jr.","position":1,"cik":"0001769750","reported_name":"McCreedy Bruce J Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-12-04T21:56:43.000Z","date":"2020-12-02","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":30000,"derivative":{"exercise_price":0.74,"exercise_date":"2021-12-01","expiration_date":"2030-12-01","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001615219-20-000116","document":"wf-form4_160711898936549.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615219/000161521920000116/wf-form4_160711898936549.xml","form_type":"4"}},{"id":2956350,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":969,"kind":"person","name":"Rosenblum Mark J","position":1,"cik":"0001329154","reported_name":"Rosenblum Mark J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec VP Finance, CFO"}}],"security":"Stock Option (right to buy)","published_at":"2020-12-04T17:02:09.000Z","date":"2020-12-02","kind":"grant","acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the options are fully vested on December 1, 2021, and 1/36 of the remaining options vest on each monthly anniversary thereafter."}],"balance_after":80000,"derivative":{"exercise_price":0.74,"expiration_date":"2030-12-01","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001615219-20-000120","document":"wf-form4_160711931578964.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1329154/000161521920000120/wf-form4_160711931578964.xml","form_type":"4"}},{"id":2956448,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":1063,"kind":"person","name":"Lieber Jonathan I","position":1,"cik":"0001350090","reported_name":"Lieber Jonathan I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-12-04T16:59:23.000Z","date":"2020-12-02","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":30000,"derivative":{"exercise_price":0.74,"exercise_date":"2021-12-01","expiration_date":"2030-12-01","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001615219-20-000118","document":"wf-form4_160711914801088.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1350090/000161521920000118/wf-form4_160711914801088.xml","form_type":"4"}},{"id":2956530,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":952,"kind":"person","name":"Lammers Paul","position":1,"cik":"0001457289","reported_name":"Lammers Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-12-04T16:55:26.000Z","date":"2020-12-02","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":30000,"derivative":{"exercise_price":0.74,"exercise_date":"2021-12-01","expiration_date":"2030-12-01","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001615219-20-000115","document":"wf-form4_160711890918329.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1457289/000161521920000115/wf-form4_160711890918329.xml","form_type":"4"}},{"id":2990794,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":92024,"kind":"person","name":"Arthur David J.","position":1,"cik":"0001769331","reported_name":"Arthur David J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-11-05T22:44:03.000Z","date":"2020-11-03","kind":"grant","acquired":true,"shares":4879,"price":0.561,"value":2737.119,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person voluntarily agreed to receive a percentage of his base salary in issuer shares  and receive these shares in lieu of net cash compensation. Shares are purchased at a  price determined pursuant to the issuer's Employee Stock Purchase Plan."}],"balance_after":86425,"source":{"system":"sec-edgar","filing":"0001615219-20-000106","document":"wf-form4_160461622928134.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615219/000161521920000106/wf-form4_160461622928134.xml","form_type":"4"}},{"id":2990881,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":969,"kind":"person","name":"Rosenblum Mark J","position":1,"cik":"0001329154","reported_name":"Rosenblum Mark J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec VP Finance, CFO"}}],"security":"Common Stock","published_at":"2020-11-05T17:42:14.000Z","date":"2020-11-03","kind":"grant","acquired":true,"shares":4723,"price":0.561,"value":2649.603,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person voluntarily agreed to receive a percentage of his base salary in issuer shares  and receive these shares in lieu of net cash compensation. Shares are  purchased at a  price determined pursuant to the issuer's Employee Stock Purchase Plan."}],"balance_after":16723,"source":{"system":"sec-edgar","filing":"0001615219-20-000104","document":"wf-form4_160461612138517.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1329154/000161521920000104/wf-form4_160461612138517.xml","form_type":"4"}},{"id":3048528,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":959,"kind":"person","name":"HANISH ARNOLD C","position":1,"cik":"0001233253","reported_name":"HANISH ARNOLD C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-24T12:08:16.000Z","date":"2020-08-21","kind":"purchase","acquired":true,"shares":4000,"price":0.98,"value":3920.0,"ownership":{"direct":true},"balance_after":11350,"source":{"system":"sec-edgar","filing":"0001615219-20-000099","document":"wf-form4_159827081943052.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1233253/000161521920000099/wf-form4_159827081943052.xml","form_type":"4"}},{"id":3050675,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":92024,"kind":"person","name":"Arthur David J.","position":1,"cik":"0001769331","reported_name":"Arthur David J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-08-20T11:59:41.000Z","date":"2020-08-19","kind":"purchase","acquired":true,"shares":1000,"price":1.01,"value":1010.0,"ownership":{"direct":false,"nature":"By son"},"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001615219-20-000095","document":"wf-form4_159792476762012.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1615219/000161521920000095/wf-form4_159792476762012.xml","form_type":"4"}},{"id":3050674,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":92024,"kind":"person","name":"Arthur David J.","position":1,"cik":"0001769331","reported_name":"Arthur David J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-08-20T11:59:41.000Z","date":"2020-08-19","kind":"purchase","acquired":true,"shares":1000,"price":1.01,"value":1010.0,"ownership":{"direct":false,"nature":"By daughter"},"balance_after":1000,"source":{"system":"sec-edgar","filing":"0001615219-20-000095","document":"wf-form4_159792476762012.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615219/000161521920000095/wf-form4_159792476762012.xml","form_type":"4"}},{"id":3053672,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":969,"kind":"person","name":"Rosenblum Mark J","position":1,"cik":"0001329154","reported_name":"Rosenblum Mark J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec VP Finance, CFO"}}],"security":"Common Stock","published_at":"2020-08-18T08:35:16.000Z","date":"2020-08-17","kind":"purchase","acquired":true,"shares":5000,"price":1,"value":5000.0,"ownership":{"direct":true},"balance_after":12000,"source":{"system":"sec-edgar","filing":"0001615219-20-000092","document":"wf-form4_159775410165354.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1329154/000161521920000092/wf-form4_159775410165354.xml","form_type":"4"}},{"id":3081449,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":92024,"kind":"person","name":"Arthur David J.","position":1,"cik":"0001769331","reported_name":"Arthur David J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-07-17T00:56:38.000Z","date":"2020-07-14","kind":"grant","acquired":true,"shares":339584,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the options are fully vested on July 14, 2021, and 1/36 of the remaining options vest on each monthly anniversary thereafter."}],"balance_after":339584,"derivative":{"exercise_price":1.32,"expiration_date":"2030-07-13","underlying":"Common Stock","underlying_shares":339584},"source":{"system":"sec-edgar","filing":"0001615219-20-000081","document":"wf-form4_159494738307174.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615219/000161521920000081/wf-form4_159494738307174.xml","form_type":"4"}},{"id":3081507,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":969,"kind":"person","name":"Rosenblum Mark J","position":1,"cik":"0001329154","reported_name":"Rosenblum Mark J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec VP Finance, CFO"}}],"security":"Stock Option (right to buy)","published_at":"2020-07-16T20:55:39.000Z","date":"2020-07-14","kind":"grant","acquired":true,"shares":49955,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the options are fully vested on July 14, 2021, and 1/36 of the remaining options vest on each monthly anniversary thereafter."}],"balance_after":49955,"derivative":{"exercise_price":1.32,"expiration_date":"2030-07-13","underlying":"Common Stock","underlying_shares":49955},"source":{"system":"sec-edgar","filing":"0001615219-20-000080","document":"wf-form4_159494732561482.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1329154/000161521920000080/wf-form4_159494732561482.xml","form_type":"4"}},{"id":3081584,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":1063,"kind":"person","name":"Lieber Jonathan I","position":1,"cik":"0001350090","reported_name":"Lieber Jonathan I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-07-16T08:33:50.000Z","date":"2020-07-14","kind":"grant","acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options fully vested on December 31, 2020."}],"balance_after":3000,"derivative":{"exercise_price":1.32,"expiration_date":"2030-07-13","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001615219-20-000077","document":"wf-form4_159490281747698.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1350090/000161521920000077/wf-form4_159490281747698.xml","form_type":"4"}},{"id":3194958,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":150355,"kind":"person","name":"Northrup Jonathan P","position":1,"cik":"0001770559","reported_name":"Northrup Jonathan P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-03-25T22:04:43.000Z","date":"2020-03-23","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options granted are fully vested on March 23, 2021."}],"balance_after":6000,"derivative":{"exercise_price":0.61,"expiration_date":"2030-03-22","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001615219-20-000031","document":"wf-form4_158517386437979.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615219/000161521920000031/wf-form4_158517386437979.xml","form_type":"4"}},{"id":3194957,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":940,"kind":"person","name":"McVicar William K.","position":1,"cik":"0001634368","reported_name":"McVicar William K.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-25T22:04:18.000Z","date":"2020-03-23","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options granted are fully vested on March 23, 2021."}],"balance_after":6000,"derivative":{"exercise_price":0.61,"expiration_date":"2030-03-22","underlying":"Stock Option (right to buy)","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001615219-20-000030","document":"wf-form4_158517384022844.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615219/000161521920000030/wf-form4_158517384022844.xml","form_type":"4"}},{"id":3194956,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":93978,"kind":"person","name":"McCreedy Bruce J Jr.","position":1,"cik":"0001769750","reported_name":"McCreedy Bruce J Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-25T22:03:57.000Z","date":"2020-03-23","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options granted are fully vested on March 23, 2021."}],"balance_after":6000,"derivative":{"exercise_price":0.61,"expiration_date":"2030-03-22","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001615219-20-000029","document":"wf-form4_158517381504869.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615219/000161521920000029/wf-form4_158517381504869.xml","form_type":"4"}},{"id":3194954,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":942,"kind":"person","name":"Burleson Tess","position":1,"cik":"0001769749","reported_name":"Burleson Tess","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-03-25T22:03:30.000Z","date":"2020-03-23","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options granted are fully vested on March 23, 2021."}],"balance_after":6000,"derivative":{"exercise_price":0.61,"expiration_date":"2030-03-22","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001615219-20-000028","document":"wf-form4_158517379260454.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615219/000161521920000028/wf-form4_158517379260454.xml","form_type":"4"}},{"id":3195108,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":959,"kind":"person","name":"HANISH ARNOLD C","position":1,"cik":"0001233253","reported_name":"HANISH ARNOLD C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-03-25T22:02:41.000Z","date":"2020-03-23","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options granted are fully vested on March 23, 2021."}],"balance_after":6000,"derivative":{"exercise_price":0.61,"expiration_date":"2030-03-22","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001615219-20-000026","document":"wf-form4_158517374401896.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1233253/000161521920000026/wf-form4_158517374401896.xml","form_type":"4"}},{"id":3194955,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":92024,"kind":"person","name":"Arthur David J.","position":1,"cik":"0001769331","reported_name":"Arthur David J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-03-25T22:02:21.000Z","date":"2020-03-23","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the options granted are fully vested on March 23, 2021, and quarterly vesting of the remaining options over 3 years."}],"balance_after":60000,"derivative":{"exercise_price":0.61,"expiration_date":"2030-03-22","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001615219-20-000025","document":"wf-form4_158517372311926.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615219/000161521920000025/wf-form4_158517372311926.xml","form_type":"4"}},{"id":3195081,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":969,"kind":"person","name":"Rosenblum Mark J","position":1,"cik":"0001329154","reported_name":"Rosenblum Mark J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec VP Finance, CFO"}}],"security":"Common Stock","published_at":"2020-03-25T18:03:05.000Z","date":"2020-03-23","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the options granted are fully vested on March 23, 2021, and quarterly vesting of the remaining options over 3 years"}],"balance_after":30000,"derivative":{"exercise_price":0.61,"expiration_date":"2030-03-22","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001615219-20-000027","document":"wf-form4_158517376702567.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1329154/000161521920000027/wf-form4_158517376702567.xml","form_type":"4"}},{"id":3195252,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":952,"kind":"person","name":"Lammers Paul","position":1,"cik":"0001457289","reported_name":"Lammers Paul","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-03-25T18:01:58.000Z","date":"2020-03-23","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options granted are fully vested on March 23, 2021."}],"balance_after":6000,"derivative":{"exercise_price":0.61,"expiration_date":"2030-03-22","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001615219-20-000024","document":"wf-form4_158517370098647.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1457289/000161521920000024/wf-form4_158517370098647.xml","form_type":"4"}},{"id":3259022,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":969,"kind":"person","name":"Rosenblum Mark J","position":1,"cik":"0001329154","reported_name":"Rosenblum Mark J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec VP Finance, CFO"}}],"security":"Common Stock","published_at":"2020-02-20T16:07:57.000Z","date":"2020-02-19","kind":"purchase","acquired":true,"shares":2000,"price":0.95,"value":1900.0,"ownership":{"direct":true},"balance_after":7000,"source":{"system":"sec-edgar","filing":"0001615219-20-000005","document":"wf-form4_158223286008604.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1329154/000161521920000005/wf-form4_158223286008604.xml","form_type":"4"}},{"id":3266060,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":81760,"kind":"person","name":"Jordan Scott","position":1,"cik":"0001769747","reported_name":"Jordan Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2020-02-18T21:48:00.000Z","date":"2020-02-18","kind":"purchase","acquired":true,"shares":11300,"price":0.9,"value":10170.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 2,538 shares of unvested Common Stock which will become fully vested on June 30, 2020."}],"balance_after":31609,"source":{"system":"sec-edgar","filing":"0001615219-20-000003","document":"wf-form4_158206246390469.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615219/000161521920000003/wf-form4_158206246390469.xml","form_type":"4"}},{"id":3273356,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":92024,"kind":"person","name":"Arthur David J.","position":1,"cik":"0001769331","reported_name":"Arthur David J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Warrants (right to buy)","published_at":"2020-02-14T02:07:23.000Z","date":"2020-02-11","kind":"purchase","acquired":true,"shares":2175,"price":0.01,"value":21.75,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Reporting Person acquired these securities in the Issuer's public offering of Class A Units on February 11, 2020. Each Class A Unit consisted of one share of Common Stock and one warrant to purchase a single share of Common Stock."}],"balance_after":2175,"derivative":{"exercise_price":1.15,"exercise_date":"2020-02-11","expiration_date":"2025-02-11","underlying":"Common Stock","underlying_shares":2175},"source":{"system":"sec-edgar","filing":"0000899243-20-004567","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615219/000089924320004567/doc4.xml","form_type":"4"}},{"id":3273355,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":150355,"kind":"person","name":"Northrup Jonathan P","position":1,"cik":"0001770559","reported_name":"Northrup Jonathan P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants (right to buy)","published_at":"2020-02-14T02:06:58.000Z","date":"2020-02-11","kind":"purchase","acquired":true,"shares":8700,"price":0.01,"value":87.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Reporting Person acquired these securities in the Issuer's public offering of Class A Units on February 11, 2020. Each Class A Unit consisted of one share of Common Stock and one warrant to purchase a single share of Common Stock."}],"balance_after":8700,"derivative":{"exercise_price":1.15,"exercise_date":"2020-02-11","expiration_date":"2025-02-11","underlying":"Common Stock","underlying_shares":8700},"source":{"system":"sec-edgar","filing":"0000899243-20-004566","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615219/000089924320004566/doc4.xml","form_type":"4"}},{"id":3273354,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":942,"kind":"person","name":"Burleson Tess","position":1,"cik":"0001769749","reported_name":"Burleson Tess","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants (right to buy)","published_at":"2020-02-14T02:05:02.000Z","date":"2020-02-11","kind":"purchase","acquired":true,"shares":4350,"price":0.01,"value":43.5,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Reporting Person acquired these securities in the Issuer's public offering of Class A Units on February 11, 2020. Each Class A Unit consisted of one share of Common Stock and one warrant to purchase a single share of Common Stock."}],"balance_after":4350,"derivative":{"exercise_price":1.15,"exercise_date":"2020-02-11","expiration_date":"2025-02-11","underlying":"Common Stock","underlying_shares":4350},"source":{"system":"sec-edgar","filing":"0000899243-20-004563","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615219/000089924320004563/doc4.xml","form_type":"4"}}],"next_cursor":"2020-02-14T02:05:02.000000Z,3273354"}